No Detail Found!

Efficacy of Acetazolamide in Refractory Epilepsy Management: A Quasi-Experimental Study

Author(s)
Muhammad Ahmed Zamir Department of Surgery, Allied Hospital,Faisalabad,Pakistan
Naveed Alam Department of Surgery, Allied Hospital,Faisalabad,Pakistan
Javed Iqbal Department of Surgery, Allied Hospital,Faisalabad,Pakistan
Muhammad Ali Rehman Department of Surgery, Allied Hospital,Faisalabad,Pakistan
Baqar Raza Department of Surgery, Allied Hospital,Faisalabad,Pakistan
Abstract
Objective: To assess the efficacy of Acetazolamide in refractory epilepsy management. Study Design: Quasi-experimental study. Place and Duration of Study: Outpatient Neurology Department, Allied Hospital, Faisalabad Pakistan, from Sep 2020 to Feb 2021. Methodology: Using a non-probability consecutive sampling technique, 260 patients of either gender aged 18 to 60 years who met the criteria of refractory epilepsy were included in the study. Group-A (n=130) received oral Acetazolamide (250 mg twice a day) plus standard antiepileptic drugs, and Group-B (n=130) received a placebo plus standard antiepileptic drugs. Patients were assessed every four weeks for a six-month response to treatment. The outcome was assessed in terms of control of refractory epilepsy. Results: Acetazolamide was effective in 88(68.2%) patients compared to Placebo Group, which showed efficacy in 41(31.8%) patients (p-value was <0.001). In addition, the mean change in the number of attacks after treatment was significantly different between Group-A (2.9±1.5) versus Group-B (1.6±1.6) (p-value <0.001). Conclusion: Acetazolamide is effective in treating refractory epilepsy.
Publication Details
Page(s) 674-677
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Efficacy, Refractory Epilepsy, Acetazolamide
0

Citations

0

Downloads

137

Views